Clinical variables | No. of patients | EBF3 expression (n) | P | |
---|---|---|---|---|
Low | High | |||
Gender | Â | Â | Â | Â |
Male | 42 | 19 | 23 | 0.473 |
Female | 63 | 33 | 30 | Â |
Age (years) | Â | Â | Â | Â |
<6 | 60 | 29 | 31 | 0.778 |
≥6 | 45 | 23 | 22 |  |
Leukocyte (/μl) |  |  |  |  |
>10000 | 61 | 32 | 29 | 0.479 |
≤10000 | 44 | 20 | 24 |  |
FAB | Â | Â | Â | Â |
M1-M6 | 93 | 47 | 46 | 0.563 |
M7 | 12 | 5 | 7 | Â |
Cytogenetics | Â | Â | Â | Â |
Favorable | 50 | 23 | 27 | 0.502 |
Intermediate | 27 | 16 | 11 | Â |
Unfavorable | 28 | 13 | 15 | Â |
MRD | Â | Â | Â | Â |
<0.25% | 49 | 28 | 21 | 0.114 |
≥0.25% | 56 | 24 | 32 |  |